OP7H:PA:PA-Ossiam Bloomberg USA PAB UCITS ETF - 1A EUR Hedged Acc (EUR)

ETF | Others |

Last Closing

USD 141.9726

Change

+0.16 (+0.11)%

Market Cap

N/A

Volume

355.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.09 (-0.19%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.90 (+0.67%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+3.00 (+0.72%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.10 (+0.27%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.47 (-0.95%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.20 (+0.62%)

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.11 (+0.30%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.39 (+0.66%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.06 (+0.30%)

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.95 (+0.57%)

USD 5.17B

ETFs Containing OP7H:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.15% 46% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.15% 45% F 48% F
Trailing 12 Months  
Capital Gain 19.72% 67% D+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.72% 65% D 73% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.06% 54% F 61% D-
Dividend Return 9.06% 53% F 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.20% 55% F 86% B+
Risk Adjusted Return 74.30% 52% F 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike